IGF2 and early-onset autosomal dominant Alzheimer disease: The unexpected increase of CSF IGF2 in HD mutation carriers is consistent with reports from Alzheimer’s disease.74,75 We postulate that elevated CSF IGF2 may reflect increased release from IGF2-producing cells (e.g. neural stem cells73) or potentially a compensatory neuroprotective mechanism in the brain.